Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds virus or component thereof
Patent
1985-05-23
1986-10-14
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds virus or component thereof
A61K 3304
Patent
active
046171894
ABSTRACT:
The toxic effects of platinum compounds used in chemotherapy can be negated by the use of a selenium-containing compound. A new selenium-containing platinum compound has been found to be useful as a so-called platinum compound type anti-cancer medicine which can self-detoxify platinum toxicity.
REFERENCES:
patent: 3892790 (1975-07-01), Tobe et al.
patent: 4080324 (1978-03-01), Hoeschele
patent: 4115418 (1978-09-01), Gale et al.
patent: 4119653 (1978-10-01), Tobe et al.
patent: 4119654 (1978-10-01), Tobe et al.
patent: 4137248 (1979-01-01), Gale et al.
patent: 4140707 (1979-02-01), Cleare et al.
patent: 4151185 (1979-04-01), Allcock et al.
patent: 4163839 (1979-08-01), Umezawa et al.
patent: 4182724 (1980-01-01), Tobe et al.
patent: 4203912 (1980-05-01), Hydes et al.
patent: 4340590 (1982-07-01), Levitt
patent: 4512977 (1985-04-01), Lundy
Merck Index, 1976 (9th Ed), pp. 1091-1092.
Dumas Philip E.
Stockel Richard F.
LandOfFree
Use of selenium-containing compounds for negating the toxic effe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of selenium-containing compounds for negating the toxic effe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selenium-containing compounds for negating the toxic effe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1339724